EcoDrugPlus

Ribosomal Protein L37

Ensembl ID : ENSOTSG00005039836
Gene Symbol: RPL37
1 Cross references
419 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSOTSG00005006021
Gene Symbol: RPL38
1 Cross references
197 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSOTSG00005041471
Gene Symbol: RPL4
1 Cross references
338 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOTSG00005024698
Gene Symbol: RPL5
3 Cross references
463 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOTSG00005038336
Gene Symbol: RPL5
3 Cross references
419 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOTSG00005024515
Gene Symbol: RPL5
3 Cross references
419 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOTSG00005034450
Gene Symbol: RPL5
3 Cross references
419 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSOTSG00005024809
Gene Symbol: RPL5
1 Cross references
463 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSOTSG00005019406
Gene Symbol: RPL6
1 Cross references
481 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSOTSG00005003349
Gene Symbol: RPL7
1 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSOTSG00005004506
Gene Symbol: RPL7
1 Cross references
487 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSOTSG00005017347
Gene Symbol: RPL7A
3 Cross references
364 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).